UVA Health
Locations
Transplant Summary
Overview
The UVA Health Cancer Center is an NCI-designated Comprehensive Cancer Center and our Stem Cell Transplant Program is FACT accredited. We perform autologous, related/unrelated allogeneic, haploidentical and cord blood transplants in adult patients. We improve lives through outstanding and compassionate transplant and cell therapy. We support our patients, families and team members through a collaborative, diverse community bound by values of empathy, caring, trust, and respect. We improve the lives of future patients through innovative research.This center has been performing allogeneic transplants since 2012 and has been an NMDP transplant center since April 2014.
Attending physicians
Adult - Karen Ballen, Joseph Clara, Krithika Shanmugasundaram, Indumathy Varadarajan, Leonid Volodin, John WagnerTransplants performed
Marrow/PBSC and double cordCord blood transplants
Adult onlyOther programs and services
Nearby affordable suites and hotels offer discounted rates for post-transplant patients. We have a housing assistance program available for low income patients and families, as well as gas and food gift cards avail for emergency use and access to a community food bank. Patients are provided with social work, mental health, and chaplaincy support throughout the process.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 140 patients.The actual 1-year survival of these patients is 80%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 69.8% and 83.3%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
301
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total Marrow6PBSC34Cord blood0Total40Marrow2PBSC77Cord blood0Total79Marrow8PBSC111Cord blood0Total119MarrowBoth marrow & PBSC 182PBSC—Cord blood—Total182MarrowBoth marrow & PBSC 301PBSC—Cord blood0Total301All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-441245-642065+8Total40Unrelated 0-18019-441445-643865+27Total79Autologous 0-18119-442145-649565+65Total182Total 0-18119-444745-6415365+100Total301Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
University of Virginia
1215 Lee Street Charlottesville, VA 22903 Phone:434-924-9333 For more information about this program: http://www.uvastemcell (Opens in a new tab)Staff
Program Director:Karen Ballen, MDProgram Coordinator:Margie Kellison, RNMedical Specialties in Program
Cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic and Autologous transplant recipients
- Adults: 3 months after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does accept patients who were transplanted at another hospital